Medicus Pharma Ltd. (MDCX)
- Previous Close
3.6350 - Open
3.0100 - Bid 2.4100 x 100
- Ask 2.7000 x 100
- Day's Range
2.3400 - 3.0400 - 52 Week Range
1.8000 - 8.9400 - Volume
1,944,091 - Avg. Volume
164,773 - Market Cap (intraday)
34.412M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-1.3700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
16.15
Medicus Pharma Ltd., a biotech/life sciences company, focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops SkinJect, with an indication for basal cell carcinoma that is drug device combination product using novel dissolvable microneedle arrays for the treatment of non-melanoma skin cancers. The company was founded in 2015 and is headquartered in Toronto, Canada.
medicuspharma.comRecent News: MDCX
View MorePerformance Overview: MDCX
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDCX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDCX
View MoreValuation Measures
Market Cap
34.48M
Enterprise Value
30.79M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
16.06
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-1.3700
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--